Research Article: Claudin 18.2 expression in digestive neuroendocrine neoplasms: a clinicopathological study
Abstract:
Claudin 18.2-targeted therapy has shown significant efficacy in treating claudin 18.2-positive cancers. However, limited systematic studies have investigated characteristics of claudin 18.2 expression in neuroendocrine neoplasms (NENs).
No summary available.